...
首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Validation of liquid and gaseous calibration techniques for quantification of propofol in breath with sorbent tube Thermal Desorption System GC-MS
【24h】

Validation of liquid and gaseous calibration techniques for quantification of propofol in breath with sorbent tube Thermal Desorption System GC-MS

机译:用吸附剂管热解吸系统验证液体校准技术,用于用吸附管热解吸系统进行呼吸呼吸中的丙酚

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Plasma concentrations of intravenous drugs cannot currently be evaluated in real time to guide clinical dosing. However, a system for estimating plasma concentration of the anesthetic propofol from exhaled breath may soon be available. Developing reliable calibration and analytical validation techniques is thus necessary. We therefore compared the established sorbent tube liquid injection technique with a gas injection procedure using a reference gas generator. We then quantified propofol with Tenax sorbent tubes in combination with gas-chromatography coupled mass spectrometry in the breath of 15 patients (101 measurements). Over the clinically relevant concentration range from 10 to 50 ppb(v), coefficient of determination was 0.995 for gas calibration; and over the range from 10 to 100 ng, coefficient of determination was 0.996 for liquid calibration. A regression comparing gas to liquid calibration had a coefficient of determination of 0.89; slope 1.05 +/- 0.01 (standard deviation). The limit of detection was 0.74 ng and the lower limit of quantification was 1.12 ng for liquid; the limit of detection was 0.90 ppb(v), and the lower limit of quantification was 1.36 ppb(v), for gas. Loaded sorbent tubes were stable for at least 14 days without significant propofol loss as determined with either method. Measurements from liquid or gas samples were comparably suitable for evaluation of patient breath samples. (C) 2017 Elsevier B.V. All rights reserved.
机译:目前不能实时评估静脉内药物的静脉内药物以指导临床给药。然而,可以很快地获得用于估算来自呼出的呼吸的血浆浓度的血浆浓度。因此需要开发可靠的校准和分析验证技术。因此,我们将建立的吸附管液喷射技术与使用参考气体发生器的气体喷射程序进行了比较。然后,将异丙酚与Tenax Sorbent管相结合,与15例患者(101次测量)中的气相色谱偶联质谱。在临床上相关的浓度范围为10至50ppb(v),气体校准的测定系数为0.995;并且在10至100 ng的范围内,用于液体校准的测定系数为0.996。将气体与液体校准的回归具有0.89的测定系数;斜率1.05 +/- 0.01(标准偏差)。检测限为0.74ng,液体的定量下限为1.12ng;检测限为0.90ppb(v),较低的定量限为1.36ppb(v),用于气体。装载的吸附剂管稳定至少14天,没有用任一方法测定的显着异丙酚损失。来自液体或气体样品的测量相当适用于评估患者呼吸样品。 (c)2017年Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号